Senate Expected to Vote on 21st Century Cures Act in September | GenomeWeb

NEW YORK (GenomeWeb) – The US Senate will not vote on its companion to the sweeping House-backed biomedical research funding bill known as the 21st Century Cures Act before its summer recess, but may do so in September, Senate Health Committee Chairman Lamar Alexander (R-Tenn.) said on Monday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.